Stage III Multiple Myeloma, AREA[OverallStatus], Open or Pending: 16 Clinical Trials, Page 1 of 2

1 2

Include Studies Not Open or Pending

5

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma

Condition(s):Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic SyndromeLast Updated:June 16, 2022Recruiting

9

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Condition(s):Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Ann Arbor Stage I Lymphoma; Ann Arbor Stage II Lymphoma; Ann Arbor Stage III Lymphoma; Ann Arbor Stage IV Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia; Gastroesophageal Junction Adenocarcinoma; Head and Neck Carcinoma; Hematopoietic and Lymphoid Cell Neoplasm; Invasive Breast Carcinoma; Kidney Carcinoma; Malignant Hepatobiliary Neoplasm; Malignant Solid Neoplasm; Melanoma; Muscle-Invasive Bladder Carcinoma; RISS Stage I Plasma Cell Myeloma; RISS Stage II Plasma Cell Myeloma; RISS Stage III Plasma Cell Myeloma; Sarcoma; Stage I Bladder Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage I Colorectal Cancer AJCC v6 and v7; Stage I Esophageal Cancer AJCC V7; Stage I Gastric Cancer AJCC V7; Stage I Lung Cancer AJCC v7; Stage I Ovarian Cancer AJCC v6 and v7; Stage I Pancreatic Cancer AJCC v6 and v7; Stage I Prostate Cancer AJCC v7; Stage I Uterine Corpus Cancer AJCC v7; Stage II Bladder Cancer AJCC v6 and v7; Stage II Breast Cancer AJCC v6 and v7; Stage II Colorectal Cancer AJCC v7; Stage II Esophageal Cancer AJCC v7; Stage II Gastric Cancer AJCC v7; Stage II Lung Cancer AJCC v7; Stage II Ovarian Cancer AJCC v6 and v7; Stage II Pancreatic Cancer AJCC v6 and v7; Stage II Prostate Cancer AJCC v7; Stage II Uterine Corpus Cancer AJCC v7; Stage III Bladder Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage III Colorectal Cancer AJCC v7; Stage III Esophageal Cancer AJCC v7; Stage III Gastric Cancer AJCC v7; Stage III Lung Cancer AJCC v7; Stage III Ovarian Cancer AJCC v6 and v7; Stage III Pancreatic Cancer AJCC v6 and v7; Stage III Prostate Cancer AJCC v7; Stage III Uterine Corpus Cancer AJCC v7; Stage IV Bladder Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7; Stage IV Colorectal Cancer AJCC v7; Stage IV Esophageal Cancer AJCC v7; Stage IV Gastric Cancer AJCC v7; Stage IV Lung Cancer AJCC v7; Stage IV Ovarian Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Stage IV Prostate Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7; Thyroid Gland CarcinomaLast Updated:April 19, 2022Not yet recruiting

1 2

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.